Men's Health
This Web page contains links to miscellaneous U.S. Food and Drug Administration (FDA) announcements that ASRM felt were relevant enough to archive on the ASRM Web Site. You can visit the FDA's web site at http://www.fda.gov/
Headlines in Reproductive Medicine
June 17, 2013
Wife: "I’ve done my share. It’s your turn now.”Husband: “If you leave me in the next five years, I’ll really feel like I sacrificed myself for nothing.”
Headlines in Reproductive Medicine
June 17, 2013
Nearly half of all infertility cases involve men, yet it’s often perceived as a woman’s issue according to local patient advocacy groups.
Headlines in Reproductive Medicine
June 11, 2013
What would you do for a long-lasting, but reversible male birth control? It'd be something you could get done once in a while, like some forms of hormonal birth control for women, instead of having to remember every time you have sex, like you do with condoms.
Headlines in Reproductive Medicine
June 10, 2013
According to a new analysis, published in The Journal of Sexual Medicine, the number of young men suffering from erectile dysfunction may be much higher than previously thought.
Press Releases
October 23, 2012
At the 68th Annual Meeting of the American Society for Reproductive Medicine, doctors from Kansas City Medical Center reported results of a survey showing differences between men’s and women’s beliefs and attitudes toward a reversible male contraceptive (RMC).
Press Releases
October 23, 2012
Research presented at the 68th Annual Meeting of the American Society for Reproductive Medicine showed the important role nutrition plays in reproductive health. The studies pointed to the impact of diet on sperm quality and on IVF success rates.
Press Releases
September 19, 2012
Some of the many fascinating research topics to be presented at the meeting include male and female fertility preservation, robotics in surgery, stem cell research, sexuality, nutrition and reproductive health, innovations in genetic screening and epigenetics. Contraception Day, Menopause Day and Surgery Day will provide a special focus on these areas while plenary lectures, seminars, symposia and workshops offer a variety of ways to learn about the latest advances in all aspects of the field.
CDC Announcements
August 24, 2012
Current CDC recommendations focus on testing individuals with known hepatitis C risk factors. However, more than 75% of American adults with hepatitis C are baby boomers and baby boomers are five times more likely than adults of other ages to be infected. Likely reasons for this disproportionate infection rate are that this generation may have received blood transfusions before screening of the blood supply began 20 years ago and because they came of age before HIV brought awareness of the risks of unprotected sex and needle sharing.
ASRM Bulletins
August 13, 2012
Today, the Centers for Disease Control and Prevention (CDC) released updated guidelines for the treatment of the sexually transmitted disease gonorrhea in response to significant increases in documented cases throughout the US to the resistance of antibiotics in treating the disease.
ASRM Bulletins
July 20, 2012
Today, the U.S. Food and Drug Administration approved Truvada (emtricitabine/tenofovir disoproxil fumarate), the first drug approved to reduce the risk of HIV infection in uninfected individuals who are at high risk of HIV infection and who may engage in sexual activity with HIV-infected partners. Truvada, taken daily, is to be used for pre-exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the risk of sexually-acquired HIV infection in adults at high risk.